EP3060229
Stöðugar vatnslausnar mótefnissamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.10.2014EP published:
25.8.2021EP application number:
14855343.1
EP translation filed:
22.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
22.10.2034Expiry date:
22.10.2026Next due date:
31.10.2026
Title:
STABLE, AQUEOUS ANTIBODY FORMULATIONS
Timeline
Today
23.10.2014EP application
25.8.2021EP Publication
22.9.2021Translation submitted
15.10.2021Registration published
22.10.2026Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
LEACH, WilliamAddress:
Gaithersburg, MD 20878, US
Name:
LEWUS, RachaelAddress:
Gaithersburg, MD 20878, US
Name:
MCGIVNEY, JamesAddress:
Gaithersburg, MD 20878, US
Name:
NEWELL, KelcyAddress:
Gaithersburg, MD 20878, US
Name:
STEWART, Kevin DouglasAddress:
Gaithersburg, MD 20878, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361895143 PDate:
24.10.2013Country:
US
Classification
Categories:
A61K 38/00, A61K 39/395, A61K 9/00, A61K 47/18, C07K 16/28, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 6.10.2021
Expires: 22.10.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.9.2022
Expires: 22.10.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 13.10.2023
Expires: 22.10.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 17.9.2024
Expires: 22.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 14.10.2025
Expires: 22.10.2026
Payer: Árnason Faktor ehf.